Cerenome, Inc. (CNSY)
1.93
+0.14
(+7.82%)
USD |
NASDAQ |
Oct 09, 16:00
1.91
-0.02
(-1.04%)
After-Hours: 17:42
Cerenome Price : 1.93 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 1.68 | 1.80 | 1.60 | 1.79 | 122726.0 |
| Oct 07, 2026 | 1.62 | 1.71 | 1.56 | 1.635 | 110931.0 |
| Oct 06, 2026 | 1.56 | 1.66 | 1.54 | 1.59 | 69638.00 |
| Oct 05, 2026 | 1.52 | 1.59 | 1.485 | 1.56 | 222893.0 |
| Oct 02, 2026 | 1.81 | 1.86 | 1.54 | 1.60 | 234618.0 |
| Oct 01, 2026 | 1.94 | 2.280 | 1.64 | 1.78 | 1.169M |
| Sep 30, 2026 | 2.02 | 2.02 | 1.84 | 1.87 | 226526.0 |
| Sep 29, 2026 | 2.03 | 2.12 | 1.86 | 1.86 | 240878.0 |
| Sep 28, 2026 | 1.99 | 2.06 | 1.90 | 2.02 | 99108.00 |
| Sep 25, 2026 | 1.92 | 2.080 | 1.92 | 1.99 | 204235.0 |
| Sep 24, 2026 | 1.96 | 1.96 | 1.86 | 1.87 | 86042.00 |
| Sep 23, 2026 | 2.01 | 2.060 | 1.93 | 1.95 | 66314.00 |
| Sep 22, 2026 | 1.93 | 2.10 | 1.911 | 2.03 | 185410.0 |
| Sep 21, 2026 | 2.03 | 2.06 | 1.90 | 1.90 | 112450.0 |
| Sep 18, 2026 | 2.01 | 2.10 | 2.00 | 2.03 | 60227.00 |
| Sep 17, 2026 | 2.08 | 2.099 | 2.00 | 2.03 | 76860.00 |
| Sep 16, 2026 | 2.11 | 2.15 | 2.000 | 2.04 | 65775.00 |
| Sep 15, 2026 | 2.19 | 2.229 | 2.09 | 2.12 | 96271.00 |
| Sep 14, 2026 | 2.30 | 2.32 | 2.17 | 2.17 | 155704.0 |
| Sep 11, 2026 | 2.40 | 2.49 | 2.31 | 2.325 | 79989.00 |
| Sep 10, 2026 | 2.47 | 2.64 | 2.36 | 2.39 | 102037.0 |
| Sep 09, 2026 | 2.66 | 2.760 | 2.489 | 2.49 | 82620.00 |
| Sep 08, 2026 | 2.74 | 2.76 | 2.60 | 2.70 | 48714.00 |
| Sep 04, 2026 | 2.89 | 3.00 | 2.74 | 2.755 | 35291.00 |
| Sep 03, 2026 | 2.96 | 3.05 | 2.86 | 2.98 | 42412.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ernexa Therapeutics, Inc. | 2.34 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.52 |
| Savara, Inc. | 4.925 |
| Vericel Corp. | 40.09 |
Price Related Metrics
| PS Ratio | 2.685 |
| Price to Book Value | 2.583 |
| Earnings Yield | -228.5% |
| Market Cap | 14.11M |